91大神

Trial of Postradiation Chemotherapy in Patients With Newly Diagnosed Ependymoma

Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神 Children's<br>\r\n<b>Locations:</b> Delaware Valley and Pensacola in Florida</p>\r\n<h3>Trial Name</h3>\r\n<p>Phase III Randomized Trial of Postradiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 years.</p>\r\n<h3>What is the trial about?</h3>\r\n<p>To determine the effects of people with ependymoma receiving chemotherapy before radiation therapy, called a short course of chemotherapy.</p>\r\n<h3>Who can participate?</h3>\r\n<p>&gt;12 months and &lt; 21 yrs of age.</p>\r\n<h3>What is involved?</h3>\r\n<p>Study length is 6 - 18 weeks. Standard cancer care treatment.</p>\r\n"}} id=text-51b849e66b class=cmp-text>

Clinical Trial

Offered by: 91大神 Children's
Locations: Delaware Valley and Pensacola in Florida

Trial Name

Phase III Randomized Trial of Postradiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 years.

What is the trial about?

To determine the effects of people with ependymoma receiving chemotherapy before radiation therapy, called a short course of chemotherapy.

Who can participate?

>12 months and < 21 yrs of age.

What is involved?

Study length is 6 - 18 weeks. Standard cancer care treatment.

Contact 91大神 Children's Clinical Trials

<strong>Trial Name:</strong> Phase III Randomized Trial of Postradiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 years.</p>\r\n<p><strong>COG#:</strong> ACNS0831</p>\r\n"}} id=text-abc6b6b316 class=cmp-text>

Trial Name: Phase III Randomized Trial of Postradiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 years.

COG#: ACNS0831

Is a Clinical Trial Right for Your Child?</h2>"}} id=text-a95976b43f class=cmp-text>

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.</p>\r\n"}} id=text-70a20647b9 class=cmp-text>

Learn more about clinical trials and get answers to questions you might have.

Two